Ohtsuka N, Konno T
1st Dept. of Surgery, Kumamoto University Medical School.
Gan To Kagaku Ryoho. 1988 Apr;15(4 Pt 2-2):1351-8.
Oily anticancer agents such as SMANCS dissolved in Lipiodol fluid (Lipiodol) were administered to 18 patients with recurrence of hepatocellular carcinoma after hepatic resection and to 87 patients with metastatic liver cancer. The following results were obtained. i) It was proved and to that Lipiodol worked as a carrier of anticancer drugs and that targeting chemotherapy could be achieved. ii) The serum AFP level and tumor size showed a decrease in 91% and 87% of patients with recurrence of hepatoma, respectively. iii) This method could be applied to extrahepatic metastasis of hepatoma, and anticancer activity was also observed in these lesions. iv) The serum CEA level was decreased in 53 patients (83%) and reduction of tumor size was observed in 32 patients (46%) with metastatic liver cancer. v) In 5 out of 7 tumors resected after arterial injection of oily anticancer agents, necrosis was found histologically in over 95% of the tumor.
将溶解在碘油(Lipiodol)中的油溶性抗癌剂如丝裂霉素丝氨酸天冬酰胺酶复合物(SMANCS)给予18例肝切除术后肝细胞癌复发患者和87例转移性肝癌患者。获得了以下结果。i)已证实碘油可作为抗癌药物的载体,并且可以实现靶向化疗。ii)肝癌复发患者中,血清甲胎蛋白(AFP)水平和肿瘤大小分别在91%和87%的患者中出现下降。iii)该方法可应用于肝癌的肝外转移,并且在这些病变中也观察到了抗癌活性。iv)转移性肝癌患者中,53例(83%)患者的血清癌胚抗原(CEA)水平下降,32例(46%)患者观察到肿瘤大小缩小。v)在7例经动脉注射油溶性抗癌剂后切除的肿瘤中,有5例在组织学上发现肿瘤坏死超过95%。